SKU(재고 관리 코드):PDMM100014
Recombinant Mouse IL-1ra/IL-1F3 protein (His tag)
Recombinant Mouse IL-1ra/IL-1F3 protein (His tag)
A DNA sequence encoding the Mouse IL-1ra/IL-1F3 protein (P25085) (Arg27-Gln178) was expressed with a C-His.
Introducing the Recombinant Mouse IL-1RA/IL-1F3 Protein (HIS TAG), a cutting-edge product designed to revolutionize the field of immunology. This meticulously engineered protein boasts a high level of purity and is produced using state-of-the-art recombinant DNA technology.
The Recombinant Mouse IL-1RA/IL-1F3 Protein (HIS TAG) is a fusion protein, incorporating a histidine (HIS) tag for easy purification and detection. This tag enables efficient isolation and identification of the protein, ensuring its integrity and quality.
With its exceptional biological activity, this protein serves as a potent antagonist of interleukin-1 (IL-1), a key mediator of inflammation and immune responses. By effectively inhibiting IL-1 signaling, the Recombinant Mouse IL-1RA/IL-1F3 Protein (HIS TAG) holds immense potential for therapeutic applications in various inflammatory diseases and autoimmune disorders.
Furthermore, this protein exhibits remarkable stability and solubility, facilitating its utilization in diverse experimental settings. Its versatility extends to compatibility with a wide range of applications, including cell culture, in vitro assays, and animal studies.
The Recombinant Mouse IL-1RA/IL-1F3 Protein (HIS TAG) is meticulously manufactured under stringent quality control measures, ensuring batch-to-batch consistency and reliability. It is supplied in a lyophilized form, preserving its activity and extending its shelf life.
In summary, the Recombinant Mouse IL-1RA/IL-1F3 Protein (HIS TAG) represents a breakthrough in immunological research, offering researchers and scientists an invaluable tool to unravel the complexities of IL-1 signaling and explore novel therapeutic avenues. Experience the pinnacle of scientific innovation with this exceptional protein, and unlock new possibilities in the realm of immunotherapy.